Restoration and regeneration of failing myocardium with cell transplantation and tissue engineering

Seminars in Thoracic and Cardiovascular Surgery

Volumn 15, Issue 3, 2003, Pages 277-286

  Fedak, Paul W M ^a   Weisel, Richard D ^a   Verma, Subodh ^a   Mickle, Donald A G ^a   Li, Ren Ke ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE;

ANGIOGENESIS; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOTRANSPLANTATION; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CELL TRANSPLANTATION; CONGESTIVE HEART FAILURE; DEFIBRILLATION; HEART ARRHYTHMIA; HEART DILATATION; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE INJURY; HEART SURGERY; HEART VENTRICLE REMODELING; HUMAN; MUSCLE REGENERATION; MUSCLE TRANSPLANTATION; NONHUMAN; REVIEW; SURGEON; TISSUE ENGINEERING;

EID: 0141520356     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-0679(03)70007-0     Document Type: Article

References (78)

1. Lloyd-Jones DM, Larson MG, Leip EP, et al: Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 106:3068-3072, 2002
2. Lefkowitz RJ, Willerson JT: Prospects for cardiovascular research. JAMA. 285:581-587, 2001
3. McMurray J, Pfeffer MA: New therapeutic options in congestive heart failure: Part II. Circulation 105:2223-2228, 2002
4. Kurrelmeyer K, Kalra D, Bozkurt B, et al: Cardiac remodeling as a consequence and cause of progressive heart failure. Clin Cardiol 21:I14-I19, 1998 (suppl 1)
5. Cohn JN, Ferrari R, Sharpe N: Cardiac remodeling - concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling: Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 35:569-582, 2000
6. Bolling SF, Smolens IA, Pagani FD: Surgical alternatives for heart failure. J Heart Lung Transplant 20:729-733, 2001
7. Jain M, DerSimonian H, Brenner DA, et al: Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation 103:1920-1927, 2001
8. Li RK, Jia ZQ, Weisel RD, et al: Cardiomyocyte transplantation improves heart function. Ann Thorac Surg 62:654-660, 1996
9. Li RK, Jia ZQ, Weisel RD, et al: Smooth muscle cell transplantation into myocardial scar tissue improves heart function. J Mol Cell Cardiol 31:513-522, 1999
10. Rajnoch C, Chachques JC, Berrebi A, et al: Cellular therapy reverses myocardial dysfunction. J Thorac Cardiovasc Surg 121:871-878, 2001
11. Weisel RD, Li RK, Mickle DA, et al: Cell transplantation comes of age. J Thorac Cardiovasc Surg 121:835-836, 2001
12. Li RK, Weisel RD, Mickle DA, et al: Autologous porcine heart cell transplantation improved heart function after a myocardial infarction. J Thorac Cardiovasc Surg 119:62-68, 2000
13. Watanabe E, Smith DM, Jr., Delcarpio JB, et al: Cardiomyocyte transplantation in a porcine myocardial infarction model. Cell Transplant 7:239-246, 1998
14. Marelli D, Desrosiers C, el Alfy M, et al: Cell transplantation for myocardial repair: an experimental approach. Cell Transplant 1:383-390, 1992
15. Scorsin M, Hagege A, Vilquin JT, et al: Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg 119:1169-1175, 2000
16. Atkins BZ, Hueman MT, Meuchel JM, et al: Myogenic cell transplantation improves in vivo regional performance in infarcted rabbit myocardium. J Heart Lung Transplant 18:1173-1180, 1999
17. Chiu RC: Cardiac cell transplantation: the autologous skeletal myoblast implantation for myocardial regeneration. Adv Card Surg 11:69-98, 1999
18. Taylor DA, Atkins BZ, Hungspreugs P, et al: Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 4:929-933, 1998
19. Ghostine S, Carrion C, Souza LC, et al: Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 106: I131-I136, 2002 (suppl 1)
20. Pouzet B, Ghostine S, Vilquin JT, et al: Is skeletal myoblast transplantation clinically relevant in the era of angiotensin-converting enzyme inhibitors? Circulation 104: I223-I228, 2001 (suppl 1)
21. Menasche P, Hagege AA, Scorsin M, et al: Myoblast transplantation for heart failure. Lancet 357:279-280, 2001
22. Pagani F, DerSimonian H, Zawadzka A, et al: Autologous skeletal myoblasts transplanted in ischemia damaged myocardium in humans. Circulation 106:II463, 2002 (abstract)
23. Menasche P: Myoblast transplantation: feasibility, safety and efficacy. Ann Med 34:314-315, 2002
24. Dib N, McCarthy PM, Campbell A, et al: Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: Interim results from the United States experience. Circulation 106:II463, 2002 (abstract)
25. Menasche P, Hagege A, Vilquin JT, et al: Transplantation of autologous skeletal myoblasts in patients with severe left ventricular function: A medium-term appraisal. Circulation 106:II463, 2002 (abstract)
26. Tomita S, Li RK, Weisel RD, et al: Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100:II247-II256, 1999 (suppl)
27. Hamano K, Li TS, Kobayashi T, et al: Angiogenesis induced by the implantation of self-bone marrow cells: a new material for therapeutic angiogenesis. Cell Transplant 9:439-443, 2000
28. Kobayashi T, Hamano K, Li TS, et al: Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model. J Surg Res 89:189-195, 2000
29. Hamano K, Li TS, Kobayashi T, et al: Therapeutic angiogenesis induced by local autologous bone marrow cell implantation. Ann Thorac Surg 73:1210-1215, 2002
30. Fuchs S, Baffour R, Zhou YF, et al: Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 37: 1726-1732, 2001
31. Tomita S, Mickle DA, Weisel RD, et al: Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 123:1132-1140, 2002
32. Shintani S, Murohara T, Ikeda H, et al: Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 103:897-903, 2001
33. Kamihata H, Matsubara H, Nishiue T, et al: Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104:1046-1052, 2001
34. Shake JG, Gruber PJ, Baumgartner WA, et al: Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 73:1919-1925, 2002
35. Kim EJ, Li RK, Weisel RD, et al: Angiogenesis by endothelial cell transplantation. J Thorac Cardiovasc Surg 122:963-971, 2001
36. Strauer BE, Brehm M, Zeus T, et al: Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106:1913-1918, 2002
37. Assmus B, Schachinger V, Teupe C, et al: Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 106:3009-3017, 2002
38. Sakai T, Li RK, Weisel RD, et al: Fetal cell transplantation: a comparison of three cell types. J Thorac Cardiovasc Surg 118:715-724, 1999
39. Ohno N, Fedak PW, Weisel RD, et al: Cell transplantation in non-ischemic dilated cardiomyopathy: A novel biological approach for ventricular restoration. Jpn J Thorac Cardiovasc Surg 50:457-460, 2002
40. Scorsin M, Hagege AA, Dolizy I, et al: Can cellular transplantation improve function in doxorubicin-induced heart failure? Circulation 98:II151-II155, 1998 (suppl)
41. Yoo KJ, Li RK, Weisel RD, et al: Heart cell transplantation improves heart function in dilated cardiomyopathic hamsters. Circulation 102:III204-III209, 2000 (suppl 3)
42. Yoo KJ, Li RK, Weisel RD, et al: Autologous smooth muscle cell transplantation improved heart function in dilated cardiomyopathy. Ann Thorac Surg 70:859-865, 2000
43. Levin HR, Oz MC, Chen JM, et al: Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation 91:2717-2720, 1995
44. Nakatani T, Sasako Y, Kobayashi J, et al: Recovery of cardiac function by long-term left ventricular support in patients with end-stage cardiomyopathy. ASAIO J 44: M516-M520, 1998
45. Athanasuleas CL, Buckberg GD, Menicanti L, et al: Optimizing ventricular shape in anterior restoration. Semin Thorac Cardiovasc Surg 13:459-467, 2001
46. Athanasuleas CL, Stanley AW, Buckberg GD, et al: Surgical anterior ventricular endocardial restoration (SAVER) for dilated ischemic cardiomyopathy. Semin Thorac Cardiovasc Surg 13:448-458, 2001
47. Athanasuleas CL, Stanley AW, Jr., Buckberg GD, et al: Surgical anterior ventricular endocardial restoration (SAVER) in the dilated remodeled ventricle after anterior myocardial infarction. RESTORE group. Reconstructive Endoventricular Surgery, returning Torsion Original Radius Elliptical Shape to the LV. J Am Coll Cardiol 37:1199-1209, 2001
48. Sakakibara Y, Tambara K, Lu F, et al: Combined procedure of surgical repair and cell transplantation for left ventricular aneurysm: an experimental study. Circulation 106:I193-I197, 2002 (suppl 1)
49. Li RK, Mickle DA, Weisel RD, et al: Human pediatric and adult ventricular cardiomyocytes in culture: assessment of phenotypic changes with passaging. Cardiovasc Res 32:362-373, 1996
50. Leobon B, Garcin I, Vilquin JT, et al: Do engrafted skeletal myoblasts contract in infarcted myocardium? Circulation 106:II549, 2002 (abstract)
51. Ruhparwar A, Tebbenjohanns J, Niehaus M, et al: Transplanted fetal cardiomyocytes as cardiac pacemaker. Eur J Cardiothorac Surg 21:853-857, 2002
52. Koh GY, Soonpaa MH, Klug MG, et al: Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs. J Clin Invest 96:2034-2042, 1995
53. Soonpaa MH, Koh GY, Klug MG, et al: Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 264:98-101, 1994
54. Roell W, Lu ZJ, Bloch W, et al: Cellular cardiomyoplasty improves survival after myocardial injury. Circulation 105:2435-2441, 2002
55. Ross RS, Borg TK: Integrins and the myocardium. Circ Res 88:1112-1119, 2001
56. 1 integrins are critical for fetal ventricular myocyte proliferation. Circ Res 87:508-515, 2000
57. Lukashev ME, Werb Z: ECM signalling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol 8:437-441, 1998
58. Lundgren E, Terracio L, Mardh S, et al: Extracellular matrix components influence the survival of adult cardiac myocytes in vitro. Exp Cell Res 158:371-381, 1985
59. Baicu CF, Stroud JD, Livesay VA, et al: Changes in extracellular collagen matrix alter myocardial systolic performance. Am J Physiol Heart Circ Physiol 284:H122-H132, 2003
60. Kim HE, Dalal SS, Young E, et al: Disruption of the myocardial extracellular matrix leads to cardiac dysfunction. J Clin Invest 106:857-866, 2000
61. Spinale FG: Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ Res 90:520-530, 2002
62. Dor V, Saab M, Coste P, et al: Left ventricular aneurysm: a new surgical approach. Thorac Cardiovasc Surg 37:11-19, 1989
63. Di Donato M, Sabatier M, Dor V, et al: Akinetic versus dyskinetic postinfarction scar: relation to surgical outcome in patients undergoing endoventricular circular patch plasty repair. J Am Coll Cardiol 29:1569-1575, 1997
64. Di Donato M, Sabatier M, Dor V, et al: Effects of the Dor procedure on left ventricular dimension and shape and geometric correlates of mitral regurgitation one year after surgery. J Thorac Cardiovasc Surg 121:91-96, 2001
65. Dor V, Sabatier M, Di Donato M, et al: Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular dysfunction: comparison with a series of large dyskinetic scars. J Thorac Cardiovasc Surg 116:50-59, 1998
66. Sinatra R, Macrina F, Braccio M, et al: Left ventricular aneurysmectomy; comparison between two techniques; early and late results. Eur J Cardiothorac Surg 12:291-297, 1997
67. Nishina T, Nishimura K, Yuasa S, et al: Initial effects of the left ventricular repair by plication may not last long in a rat ischemic cardiomyopathy model. Circulation 104: 241-245, 2001 (suppl 1)
68. Li RK, Yau TM, Weisel RD, et al: Construction of a bioengineered cardiac graft. J Thorac Cardiovasc Surg 119:368-375, 2000
69. Akhyari P, Fedak PWM, Weisel RD, et al: Mechanical stretch regimen enhances the formation of bioengineered autologous cardiac muscle grafts. Circulation 106:I137-I142, 2002 (suppl 1)
70. Carrier RL, Papadaki M, Rupnick M, et al: Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol Bioeng 64:580-589, 1999
71. Kim BS, Putnam AJ, Kulik TJ, et al: Optimizing seeding and culture methods to engineer smooth muscle tissue on biodegradable polymer matrices. Biotechnol Bioeng 57: 46-54, 1998
72. Kim BS, Nikolovski J, Bonadio J, et al: Cyclic mechanical strain regulates the development of engineered smooth muscle tissue. Nat Biotechnol 17:979-983, 1999
73. Li RK, Jia ZQ, Weisel RD, et al: Survival and function of bioengineered cardiac grafts. Circulation 100:63-69, 1999 (suppl)
74. Ozawa T, Mickle DA, Weisel RD, et al: Optimal biomaterial for creation of autologous cardiac grafts. Circulation 106:I176-I182, 2002 (suppl 1)
75. Ozawa T, Mickle DA, Weisel RD, et al: Histologic changes of nonbiodegradable and biodegradable biomaterials used to repair right ventricular heart defects in rats. J Thorac Cardiovasc Surg 124:1157-1164, 2002
76. Leor J, Aboulafia-Etzion S, Dar A, et al: Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation 102:III56-III61, 2000 (suppl 3)
77. Vacanti JP, Langer R. Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet 354:32-34, 1999 (suppl 1)
78. Kelley ST, Malekan R, Gorman JH 3rd, et al: Restraining infarct expansion preserves left ventricular geometry and function after acute anteroapical infarction. Circulation 99:135-142, 1999